Persistence of SARS-CoV-2 specific B- and T-cell responses in convalescent COVID-19 patients 6-8 months after the infection. Sherina et al.
Published: 2 February 2021| Version 1 | DOI: 10.17632/8h5wt8nvnj.1
Contributors:
Harold Marcotte, Qiang Pan-HammarströmDescription
Table S1 Demographic and clinical characteristics of the COVID-19 patients. Related to Table 1 and Figure 1. Table S2 Statistical comparison (p values) of SARS-CoV-2 specific B cells and T cells in COVID-19 patient samples collected at different time points. Related to Figures 6A-E. Table S3 Statistical comparison (p values) of SARS-CoV-2 specific B cells and T cells in COVID-19 patient samples in relation to disease severity. Related to Figure 6A-E.
Files
Institutions
Karolinska Institutet
Categories
Immune Response, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19